Security key
45845P108
- Security type / class
- Equity / COM
- Total 13F shares
- 34,971,157
- Total 13F value
- $386,778,183
- Share change
- +6,433,896
- Put/Call ratio
- 214%
- SEC-reported price per share
- $11.06
- Number of holders
- 123
- Value change
- +$65,262,601
- Number of buys
- 62
- Number of sells
- 74
Open additional details 1 more signal available
Report period
Q2 2023
Institutions
123
Top holders
10
Broader feeds
Ownership snapshot
Top reported holders of ICPT - INTERCEPT PHARMACEUTICALS IN - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
123
Shares
34,971,157
Rows available
123
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
142
Q2 2023 holders
123
Holder diff
-19
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|